BMY logo

Bristol-Myers Squibb (BMY) Accounts Payable

Annual Accounts Payable

$3.26 B
+$219.00 M+7.20%

December 31, 2023

Summary

Performance

1-Year Change

+7.2%

3-Year Change

+20.13%

5-Year Change

+72.25%

15-Year Change

+44.97%

BMY Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

98.66%
BMY annual accounts payable is higher than 98.66% of companies in Healthcare sector

High & Low

All-time High

$3.26 B
BMY annual accounts payable is currently at an all-time high

3-Year Low

$2.95 B
BMY annual accounts payable is currently +10.51% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
BMY previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
BMY next annual earnings announcement has not yet been scheduled

OtherBMYbalance sheetmetrics:

Annual Accounts Receivable

$8.88 B
BMY annual accounts receivable is $8.88 billion

Annual Total Liabilities

$65.67 B
BMY annual total liabilities is $65.67 billion

Annual Total Assets

$95.16 B
BMY annual total assets is $95.16 billion

Annual Current Assets

$11.46 B
BMY annual total current assets is $11.46 billion

Quarterly Accounts Payable

$3.47 B
-$282.00 M-7.52%

September 30, 2024

Summary

Performance

3-Month Change

-7.52%

1-Year Change

+6.44%

3-Year Change

+6.44%

5-Year Change

+6.44%

BMY Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

98.72%
BMY quarterly accounts payable is higher than 98.72% of companies in Healthcare sector

High & Low

All-time High

$3.75 B
BMY quarterly accounts payable is currently -7.52% below its historical high of $3.75 billion

3-Year Low

$2.60 B
BMY quarterly accounts payable is currently +33.68% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
BMY previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
BMY next earnings announcement has not yet been scheduled

OtherBMYbalance sheetmetrics:

Quarterly Accounts Receivable

$9.32 B
BMY quarterly accounts receivable is $9.32 billion

Quarterly Total Liabilities

$76.47 B
BMY quarterly total liabilities is $76.47 billion

Quarterly Total Assets

$93.67 B
BMY quarterly total assets is $93.67 billion

Quarterly Current Assets

$28.07 B
BMY quarterly total current assets is $28.07 billion

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

BMY Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+7.2%+6.4%
3 y3 years+20.1%+6.4%
5 y5 years+72.3%+6.4%

BMY Accounts Payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+10.5%-7.5%+33.7%
5 y5-yearat high+33.3%-7.5%+42.1%
alltimeall timeat high+586.1%-7.5%+780.5%

Bristol-Myers Squibb Accounts Payable History

DateAnnualQuarterly
Sep 2024
-
$3.47 B(-7.5%)
Jun 2024
-
$3.75 B(+6.0%)
Mar 2024
-
$3.54 B(+8.6%)
Dec 2023
$3.26 B(+7.2%)
$3.26 B(+15.9%)
Sep 2023
-
$2.81 B(-8.3%)
Jun 2023
-
$3.07 B(-3.9%)
Mar 2023
-
$3.19 B(+5.1%)
Dec 2022
$3.04 B(+3.1%)
$3.04 B(+17.1%)
Sep 2022
-
$2.60 B(-10.0%)
Jun 2022
-
$2.88 B(-2.1%)
Mar 2022
-
$2.94 B(-0.2%)
Dec 2021
$2.95 B(+8.7%)
$2.95 B(+9.4%)
Sep 2021
-
$2.69 B(-25.3%)
Jun 2021
-
$3.61 B(+21.4%)
Mar 2021
-
$2.97 B(+9.5%)
Dec 2020
$2.71 B(+11.0%)
$2.71 B(+11.1%)
Sep 2020
-
$2.44 B(-14.4%)
Jun 2020
-
$2.85 B(-7.1%)
Mar 2020
-
$3.07 B(+25.5%)
Dec 2019
$2.44 B(+29.2%)
$2.44 B(+29.5%)
Sep 2019
-
$1.89 B(-5.8%)
Jun 2019
-
$2.00 B(+1.5%)
Mar 2019
-
$1.98 B(+4.4%)
Dec 2018
$1.89 B(-15.8%)
$1.89 B(+6.7%)
Sep 2018
-
$1.77 B(-5.3%)
Jun 2018
-
$1.87 B(+8.6%)
Mar 2018
-
$1.73 B(-23.3%)
Dec 2017
$2.25 B(+35.1%)
$2.25 B(+32.3%)
Sep 2017
-
$1.70 B(+9.5%)
Jun 2017
-
$1.55 B(+3.2%)
Mar 2017
-
$1.50 B(-9.7%)
Dec 2016
$1.66 B(+6.3%)
$1.66 B(+18.3%)
Sep 2016
-
$1.41 B(-6.4%)
Jun 2016
-
$1.50 B(-2.5%)
Mar 2016
-
$1.54 B(-1.4%)
Dec 2015
$1.56 B(-37.1%)
$1.56 B(+25.3%)
Sep 2015
-
$1.25 B(-32.1%)
Jun 2015
-
$1.84 B(-21.6%)
Mar 2015
-
$2.35 B(-5.7%)
Dec 2014
$2.49 B(-2.8%)
$2.49 B(-3.2%)
Sep 2014
-
$2.57 B(+6.8%)
Jun 2014
-
$2.40 B(-3.9%)
Mar 2014
-
$2.50 B(-2.2%)
Dec 2013
$2.56 B(+16.2%)
$2.56 B(+3.8%)
Sep 2013
-
$2.47 B(+5.1%)
Jun 2013
-
$2.35 B(+12.8%)
Mar 2013
-
$2.08 B(-5.6%)
Dec 2012
$2.20 B(-15.4%)
$2.20 B(+5.6%)
Sep 2012
-
$2.08 B(-2.3%)
Jun 2012
-
$2.13 B(-10.5%)
Mar 2012
-
$2.38 B(-8.4%)
Dec 2011
$2.60 B(+31.3%)
$2.60 B(+13.6%)
Sep 2011
-
$2.29 B(-4.5%)
Jun 2011
-
$2.40 B(+17.9%)
Mar 2011
-
$2.04 B(+2.7%)
Dec 2010
$1.98 B(+15.9%)
$1.98 B(+18.0%)
Jun 2010
-
$1.68 B(-4.1%)
Mar 2010
-
$1.75 B(+2.4%)
Dec 2009
$1.71 B(+11.5%)
$1.71 B(-4.7%)
Sep 2009
-
$1.80 B(-0.3%)
Jun 2009
-
$1.80 B(+6.3%)
Mar 2009
-
$1.70 B(+10.4%)
Dec 2008
$1.53 B(+6.4%)
$1.53 B(+6.5%)
Sep 2008
-
$1.44 B(-11.5%)
Jun 2008
-
$1.63 B(+3.4%)
Mar 2008
-
$1.57 B(+9.2%)
Dec 2007
$1.44 B
$1.44 B(+7.4%)
Sep 2007
-
$1.34 B(-4.5%)
Jun 2007
-
$1.41 B(+6.9%)
DateAnnualQuarterly
Mar 2007
-
$1.31 B(+6.1%)
Dec 2006
$1.24 B(-21.5%)
$1.24 B(+5.5%)
Sep 2006
-
$1.17 B(-7.0%)
Jun 2006
-
$1.26 B(+1.5%)
Mar 2006
-
$1.24 B(-21.2%)
Dec 2005
$1.58 B(-25.8%)
$1.58 B(+17.7%)
Sep 2005
-
$1.34 B(+1.7%)
Jun 2005
-
$1.32 B(-29.5%)
Mar 2005
-
$1.87 B(-11.9%)
Dec 2004
$2.13 B(+12.4%)
$2.13 B(+17.4%)
Sep 2004
-
$1.81 B(+5.5%)
Jun 2004
-
$1.72 B(+1.8%)
Mar 2004
-
$1.69 B(-10.9%)
Dec 2003
$1.89 B(+22.1%)
$1.89 B(+13.8%)
Sep 2003
-
$1.66 B(-9.1%)
Jun 2003
-
$1.83 B(+21.3%)
Mar 2003
-
$1.51 B(-2.7%)
Dec 2002
$1.55 B(+4.9%)
$1.55 B(+8.7%)
Sep 2002
-
$1.43 B(-3.8%)
Jun 2002
-
$1.48 B(+3.1%)
Mar 2002
-
$1.44 B(-2.7%)
Dec 2001
$1.48 B(-13.2%)
$1.48 B(+3.2%)
Sep 2001
-
$1.43 B(-12.1%)
Jun 2001
-
$1.63 B(+1.3%)
Mar 2001
-
$1.61 B(-5.5%)
Dec 2000
$1.70 B(+2.7%)
$1.70 B(+19.0%)
Sep 2000
-
$1.43 B(-9.8%)
Jun 2000
-
$1.59 B(+4.8%)
Mar 2000
-
$1.51 B(-8.6%)
Dec 1999
$1.66 B(+20.1%)
$1.66 B(+10.0%)
Sep 1999
-
$1.51 B(+9.7%)
Jun 1999
-
$1.37 B(+8.0%)
Mar 1999
-
$1.27 B(-7.9%)
Dec 1998
$1.38 B(+35.7%)
$1.38 B(+29.3%)
Sep 1998
-
$1.07 B(-0.4%)
Jun 1998
-
$1.07 B(-4.0%)
Mar 1998
-
$1.12 B(+9.7%)
Dec 1997
$1.02 B(-4.4%)
$1.02 B(+3.8%)
Sep 1997
-
$980.00 M(+1.2%)
Jun 1997
-
$968.00 M(-4.5%)
Mar 1997
-
$1.01 B(-4.7%)
Dec 1996
$1.06 B(+25.5%)
$1.06 B(+34.0%)
Sep 1996
-
$794.00 M(-11.4%)
Jun 1996
-
$896.00 M(+6.3%)
Mar 1996
-
$843.00 M(-0.6%)
Dec 1995
$848.00 M(+22.4%)
$848.00 M(+11.7%)
Sep 1995
-
$759.00 M(+1.9%)
Jun 1995
-
$745.00 M(-3.6%)
Mar 1995
-
$773.00 M(+11.5%)
Dec 1994
$693.00 M(+6.8%)
$693.00 M(+19.9%)
Sep 1994
-
$578.00 M(-6.6%)
Jun 1994
-
$619.00 M(-2.1%)
Mar 1994
-
$632.00 M(-2.6%)
Dec 1993
$649.00 M(+15.5%)
$649.00 M(+24.1%)
Jun 1993
-
$523.00 M(+4.0%)
Mar 1993
-
$503.00 M(-10.5%)
Dec 1992
$562.00 M(+4.7%)
$562.00 M(+9.1%)
Sep 1992
-
$515.00 M(-4.6%)
Jun 1992
-
$540.00 M(+2.9%)
Mar 1992
-
$525.00 M(-2.2%)
Dec 1991
$537.00 M(+1.3%)
$537.00 M(+18.0%)
Sep 1991
-
$455.00 M(-7.1%)
Jun 1991
-
$490.00 M(-6.8%)
Mar 1991
-
$526.00 M(-0.8%)
Dec 1990
$530.00 M(+11.6%)
$530.00 M(+27.4%)
Sep 1990
-
$416.00 M(+0.5%)
Jun 1990
-
$414.00 M(+5.1%)
Mar 1990
-
$394.00 M(-17.1%)
Dec 1989
$475.00 M
$475.00 M

FAQ

  • What is Bristol-Myers Squibb annual accounts payable?
  • What is the all time high annual accounts payable for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb annual accounts payable year-on-year change?
  • What is Bristol-Myers Squibb quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb quarterly accounts payable year-on-year change?

What is Bristol-Myers Squibb annual accounts payable?

The current annual accounts payable of BMY is $3.26 B

What is the all time high annual accounts payable for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high annual accounts payable is $3.26 B

What is Bristol-Myers Squibb annual accounts payable year-on-year change?

Over the past year, BMY annual accounts payable has changed by +$219.00 M (+7.20%)

What is Bristol-Myers Squibb quarterly accounts payable?

The current quarterly accounts payable of BMY is $3.47 B

What is the all time high quarterly accounts payable for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high quarterly accounts payable is $3.75 B

What is Bristol-Myers Squibb quarterly accounts payable year-on-year change?

Over the past year, BMY quarterly accounts payable has changed by +$210.00 M (+6.44%)